Cancer care shouldn't end with treating the cancer. For many patients, the effects of cancer treatment can persist long after surgery, chemotherapy, or radiation have ended. Pain, fatigue, weakness, lymphedema, neuropathy, and reduced mobility can profoundly affect a person's ability to return to everyday life. In this episode of @ProgressPotent1 I'm joined by Dr. @EricWisotzkyMD, Director of Cancer Rehabilitation at @MedStarNRH and Ashley Smith, who shares her personal experience navigating breast cancer and rehabilitation. We explore how cancer rehabilitation can help patients prepare for treatment, manage side effects while undergoing care, and regain strength, mobility, function, and independence over the long term. From prehabilitation and physical therapy to chronic pain management, lymphedema, radiation fibrosis, and the future of personalized cancer recovery, we'll discuss why rehabilitation deserves a much larger role in the cancer care journey. Because surviving cancer is only part of the story. Helping people live well afterward matters, too. Watch now - youtube.com/watch?v=oHW3bb0E… #CancerRehabilitation #CancerCare #CancerSurvivorship #BreastCancer #CancerRecovery #Healthcare #ProgressPotentialAndPossibilities @ScottCircle

What if one of the biggest obstacles to AI-driven drug discovery isn't AI at all? It's DATA. We now have extraordinary AI models capable of analyzing biological systems in ways that were unimaginable just a few years ago. But some of the most valuable biological data in existence is sitting inside pharmaceutical companies, biotech companies, universities and research organizations - often locked away because the organizations that generated it can't simply give away their intellectual property. So what happens if we could let AI learn from that proprietary data without requiring the data itself to leave its owner's control? That's the problem Dr. @HarlanRobins, Ph.D. is tackling with Harell Data. Dr. Robins brings a fascinating perspective to this question. He trained as a physicist, became an early computational biologist, helped build the Computational Biology Program at @fredhutch, and then spent more than 16 years as Co-Founder and Chief Scientific Officer of @AdaptiveBiotech, helping decode the adaptive immune system at scale. Now he's thinking about the next bottleneck: Can we build an economic and technological infrastructure that allows AI to learn from the world's most valuable biological datasets - while allowing the people who created those datasets to retain control and participate in the value they generate? Imagine a pharmaceutical company, two biotech companies, an AI developer and an experimental laboratory all contributing different pieces of the puzzle - without simply handing over their proprietary data. Could that create a new flywheel for scientific discovery? Data → AI → prediction → experiment → new data → better AI. That's what we explore with Dr. Robins on the latest episode of @ProgressPotent1 Watch now - youtube.com/watch?v=l_AJtLIY… #AI #Biotech #DrugDiscovery #ComputationalBiology #ScientificData #ArtificialIntelligence #HarellData @orangefiery @DiDop @CoreWeave @AAlphaBio

What if we could see inside the breast without X-rays, without compression, and without contrast agents? That’s the premise behind a very different approach to breast imaging being developed by QT Imaging - @QTIHoldings My guest on @ProgressPotent1 is Dr. Raluca Dinu, Ph.D., CEO of QT Imaging, whose background spans physics, optics, semiconductor technology and technology commercialization. QT’s Breast Acoustic CT uses sound waves to generate 3D images of the breast - including quantitative measurements such as tissue speed of sound and fibroglandular volume. But the bigger question isn't simply whether we can create another image. Can quantitative imaging help us see what conventional imaging may miss, particularly in dense breasts? Can it eventually tell us more about the physical characteristics of a lesion? And could repeatedly measuring those characteristics allow us to monitor how a tumor changes over time - potentially giving physicians another way to assess treatment response? We discuss the physics behind Breast Acoustic CT, how it compares with mammography and MRI, what the early clinical studies have actually shown, and the significance of QT's growing real-world experience. A fascinating look at how sound could potentially change the way we see breast cancer. Watch now - youtube.com/watch?v=pGBNibUc… #BreastCancer #BreastImaging #Mammography #MedicalImaging #Ultrasound #MedTech #CancerResearch #QTImaging #ProgressPotentialAndPossibilities @CoreIR_

THE CAREGIVING CRISIS What happens when caring for someone you love becomes a second full-time job - while the healthcare system, the economy and even our technology often fail to recognize the person doing the caring? For journalist, filmmaker, author and caregiving advocate @RichardLui, that question became deeply personal when his father developed Alzheimer’s. It changed the direction of his life - leading to documentaries, his book Enough About Me, the Caregiving Moonshot, and now an ambitious effort at the @UMich called CAREGenome, which is exploring how data and AI might help us understand what Richard calls the “last three feet of care.” And now Richard has taken that mission to a new national platform with Because We Care, his new series on @MSNOWNews. In our @ProgressPotent1 conversation, Richard talks about his own experience as a caregiver, the hidden human and economic dimensions of caregiving, the emerging care economy, caregiver mental health and loneliness, CAREGenome, spatial AI, and the question of whether technology can actually make care more human rather than less. And Richard brought something special to our conversation: clips from his new Because We Care conversations with @EmmaHeming and @IamLaurenMiller and @Sethrogen, sharing very different experiences of caregiving and dementia. Those stories bring the discussion back to the most important part of all: The human beings behind the data. Watch now - youtube.com/watch?v=Q6_hBF53… #Caregiving #Dementia #Alzheimers #Aging #AI #ArtificialIntelligence #CAREGenome #SpatialAI #CareEconomy #HealthTech #AgeTech #RichardLui #BecauseWeCare @laarnid1 @MSNOWComms @WeAreHFC @NBCNews @beUNCONDITIONAL @SkyBlossomFilm @startuphealth @YNB @mariashriver

A robot can recognize a person. But can it understand one? As AI moves from our screens into the physical world, robots increasingly have to operate in environments that are messy, unpredictable and fundamentally human. They need to navigate around us. Understand our instructions. Predict our movements. Interpret context. Recognize when we're uncertain or confused. And sometimes, perhaps most importantly, know when they don't understand what we're trying to do. That's where the emerging concept of social intelligence comes in. On this episode of @ProgressPotent1 I spoke with Brian Hartzband, President of U.S. Operations at @GMEXRobotics, about the company's "Terminal + Brain" approach to physical AI and its planned strategic investment in MediaMeta.AI, which focuses on human behavioral modeling and social intelligence. We explored a bigger question: Can robots learn to understand human behavior - not just recognize it? And what would it take to prove that they actually can? From embodied AI and robot perception to human intent, social context, behavioral prediction and the challenges of putting autonomous machines into hospitals, restaurants, hotels and homes, this is where AI gets very interesting. Can robots understand us? Watch now - youtube.com/watch?v=9yxb10xX… #PhysicalAI #EmbodiedAI #Robotics #ArtificialIntelligence #SocialIntelligence #HumanoidRobots #Robots #AI #RoboticsTechnology #FutureOfRobotics #HumanRobotInteraction #MachineLearning #AutonomousRobots #FutureOfAI @CoreIR_

For decades, biometric technology has been trying to answer a deceptively simple question: WHO ARE YOU? A face. A fingerprint. An iris. Today, AI can turn these biological characteristics into highly sophisticated mathematical representations and compare them against enormous identity databases. But something much bigger is happening. The technology is evolving from biometric recognition toward Vision AI - systems that can potentially recognize not just who is in an image, but what is happening around them. People. Vehicles. Objects. Weapons. Behavior. Events. And that raises some fascinating questions: How accurate is facial recognition in the messy real world? What happens when you search for one person among millions? Can AI actually understand human behavior - or is it still primarily recognizing patterns? How do we protect biometric information? And as generative AI becomes capable of creating increasingly convincing synthetic faces, voices and videos, are we entering an arms race between biometric authentication and AI-powered deception? On this episode of @ProgressPotent1 I'm joined by B. Scott Swann, CEO of @ROC_VisionaryAI and a longtime leader in biometrics, computer vision and identity technology. Scott spent nearly two decades at the @FBI before moving into senior leadership at MorphoTrak and IDEMIA National Security Solutions, and now leads ROC as it develops technologies spanning facial, fingerprint and iris recognition, liveness detection, video analytics and Vision AI. We've gone from asking AI: "Who is this?" Now we're asking: "What does AI actually see?" Watch now - youtube.com/watch?v=Xnx9nJZ5… #AI #Biometrics #FacialRecognition #VisionAI #ComputerVision #ArtificialIntelligence #IdentityTechnology #FutureOfAI @CoreIR_

What if we could teach the immune system to stop attacking the liver? That's one of the biggest questions emerging from the science of Primary Biliary Cholangitis (PBC) - a rare autoimmune disease that disproportionately affects women and can cause progressive liver damage. But PBC isn't simply a story about liver enzymes and disease progression. For many patients, the most difficult parts of the disease can be invisible: debilitating fatigue, relentless itching, brain fog, anxiety about the future and the social stigma of an illness that other people simply can't see. A new national Voice of PBC survey from The @PBCers Organization, capturing the experiences of 210 people living with PBC, brings that hidden burden into sharp focus. On this episode of @ProgressPotent1, I spoke with Carol Roberts - @pbcercarol - President of @PBCers Organization, about what it's actually like to live with PBC - and where the science is headed. We explore: • Why PBC is so often discovered through routine bloodwork; • Why fatigue and pruritus can be so debilitating; • Why patients are still told, "You don't look sick"; • The evolution from ursodeoxycholic acid to newer therapies including elafibranor and seladelpar; • What the Ocaliva experience taught us about drug development; • Why improving a biomarker isn't necessarily the same as improving a patient's life; • And perhaps most intriguingly - whether the next generation of PBC therapies could move beyond treating the consequences of autoimmunity and toward immune tolerance and reprogramming. Could we eventually teach the immune system to leave the bile ducts alone? That's where the future of PBC research gets particularly fascinating. Watch now - youtube.com/watch?v=TcVl8QbC… #PBC #PrimaryBiliaryCholangitis #AutoimmuneDisease #RareDisease #LiverDisease #Immunology #DrugDevelopment #WomensHealth #MedicalResearch #FutureOfMedicine @FINNPartners